Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
. (2009) Postgraduate Courses. Scandinavian Journal of Gastroenterology 44:sup246, pages 1-41.
Read now
Read now
John Willy Haukeland, Zbigniew Konopski, Heidi Beate Eggesbø, Hilde Løland von Volkmann, Gabriele Raschpichler, Kristian Bjøro, Terese Haaland, Else Marit Løberg & Kåre Birkeland. (2009) Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial. Scandinavian Journal of Gastroenterology 44:7, pages 853-860.
Read now
Read now
Articles from other publishers (34)
Rong Xie, Shaodong Chen, Fang Li, Liu Yang & Bangliang Yu. (2022) Pirfenidone attenuates nonalcoholic fatty liver disease through activation of the nuclear factor erythroid 2‐related factor 2 (Nrf2) signaling pathway. Journal of Biochemical and Molecular Toxicology 37:2.
Crossref
Crossref
Hager H. Shaaban, Ibrahim Alzaim, Ahmed El-Mallah, Rania G. Aly, Ahmed F. El-Yazbi & Ahmed Wahid. (2022) Metformin, pioglitazone, dapagliflozin and their combinations ameliorate manifestations associated with NAFLD in rats via anti-inflammatory, anti-fibrotic, anti-oxidant and anti-apoptotic mechanisms. Life Sciences 308, pages 120956.
Crossref
Crossref
Shagufta Akhtar & Azhar Khan. (2020) Analysis of Metabolic Biomarkers in Non-Alcoholic Fatty Liver Disease (NAFLD); A Comprehensive Review. Advanced Journal of Graduate Research 9:1, pages 46-58.
Crossref
Crossref
Alfonso Varela-López, Pedro Bullón, César L. Ramírez-Tortosa, María D. Navarro-Hortal, María Robles-Almazán, Beatriz Bullón, Mario D. Cordero, Maurizio Battino & José L. Quiles. (2020) A Diet Rich in Saturated Fat and Cholesterol Aggravates the Effect of Bacterial Lipopolysaccharide on Alveolar Bone Loss in a Rabbit Model of Periodontal Disease. Nutrients 12:5, pages 1405.
Crossref
Crossref
Eun-Ock Park, Eun Ju Bae, Byung-Hyun Park & Soo-Wan Chae. (2020) The Associations between Liver Enzymes and Cardiovascular Risk Factors in Adults with Mild Dyslipidemia. Journal of Clinical Medicine 9:4, pages 1147.
Crossref
Crossref
Kerong Shi, Ranran Li, Zhongjin Xu & Qin Zhang. (2020) Identification of Crucial Genetic Factors, Such as PPARγ, that Regulate the Pathogenesis of Fatty Liver Disease in Dairy Cows Is Imperative for the Sustainable Development of Dairy Industry. Animals 10:4, pages 639.
Crossref
Crossref
Xiaojing Wang, Lan Li, Hongwu Wang, Fang Xiao & Qin Ning. (2019) Epoxyeicosatrienoic acids alleviate methionine‐choline‐deficient diet–induced non‐alcoholic steatohepatitis in mice. Scandinavian Journal of Immunology 90:3.
Crossref
Crossref
Marie Boyle & Quentin M. Anstee. 2019. Evidence-based Gastroenterology and Hepatology 4e. Evidence-based Gastroenterology and Hepatology 4e
523
546
.
Yuhui Wang, Xiyang Zhang, Bo Yuan, Xi Lu, Dongxuan Zheng, Kefeng Zhang, Mingli Zhong, Xiaotian Xu & Xiaoqun Duan. (2019)
GVS-12 attenuates non-alcoholic steatohepatitis by suppressing inflammatory responses
via
PPARγ/STAT3 signaling pathways
. RSC Advances 9:17, pages 9555-9564.
Crossref
Crossref
Ping Wang, Hua Qiang, Yan Song, Ying Dang, Hui Luan, Lifei Cao, Qing Cui & Gang Tian. (2019) Association between Nonalcoholic Fatty Liver and Gensini Score in Patients with Coronary Heart Disease: A Cross-Sectional Study. Cardiology 144:3-4, pages 90-96.
Crossref
Crossref
Preya Janubhai Patel, Fabrina Hossain, Leigh Ula Horsfall, Xuan Banh, Kelly Lee Hayward, Suzanne Williams, Tracey Johnson, Nigel Neil Brown, Nivene Saad, Patricia Casarolli Valery, Katharine Margaret Irvine, Andrew Donald Clouston, Katherine Anne Stuart, Anthony William Russell & Elizabeth Ellen Powell. (2018) Controlled attenuation parameter in NAFLD identifies risk of suboptimal glycaemic and metabolic control. Journal of Diabetes and its Complications 32:8, pages 799-804.
Crossref
Crossref
Preya J. Patel, Xuan Banh, Leigh U. Horsfall, Kelly L. Hayward, Fabrina Hossain, Tracey Johnson, Katherine A. Stuart, Nigel N. Brown, Nivene Saad, Andrew Clouston, Katharine M. Irvine, Anthony W. Russell, Patricia C. Valery, Suzanne Williams & Elizabeth E. Powell. (2018) Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis. Internal Medicine Journal 48:2, pages 144-151.
Crossref
Crossref
Behnam Rabiee, Farzin Roozafzai, Gholam Reza Hemasi, Hossein Poustchi, Hossein Keyvani, Mahmood Reza Khonsari, Hossein Ajdarkosh, Mansooreh Maadi, Fatemeh Sima Saeedian & Farhad Zamani. (2017) The Prevalence of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus in an Iranian Population. Middle East Journal of Digestive Diseases 9:2, pages 86-93.
Crossref
Crossref
Mehdi Birjandi, Seyyed Mohammad Taghi Ayatollahi, Saeedeh Pourahmad & Ali Reza Safarpour. (2016) Prediction and Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) and Identification of Its Associated Factors Using the Classification Tree Method. Iranian Red Crescent Medical Journal 18:11.
Crossref
Crossref
Zaki A. Sherif, Armana Saeed, Shima Ghavimi, Seyed-Mehdi Nouraie, Adeyinka O. Laiyemo, Hassan Brim & Hassan Ashktorab. (2016) Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations. Digestive Diseases and Sciences 61:5, pages 1214-1225.
Crossref
Crossref
Isabel Freitas, Eleonora Boncompagni, Eleonora Tarantola, Cristian Gruppi, Vittorio Bertone, Andrea Ferrigno, Gloria Milanesi, Rita Vaccarone, M. Enrica Tira & Mariapia Vairetti. (2016)
In Situ
Evaluation of Oxidative Stress in Rat Fatty Liver Induced by a Methionine- and Choline-Deficient Diet
. Oxidative Medicine and Cellular Longevity 2016, pages 1-14.
Crossref
Crossref
Kari Otterdal, John Willy Haukeland, Arne Yndestad, Tuva B Dahl, Sverre Holm, Filip M Segers, Ivar P Gladhaug, Zbigniew Konopski, Jan Kristian Damås, Bente Halvorsen & Pål Aukrust. (2015) Increased Serum Levels of LIGHT/TNFSF14 in Nonalcoholic Fatty Liver Disease: Possible Role in Hepatic Inflammation. Clinical and Translational Gastroenterology 6:7, pages e95.
Crossref
Crossref
Kamila Kochan, Edyta Maslak, Christoph Krafft, Renata Kostogrys, Stefan Chlopicki & Malgorzata Baranska. (2015) Raman spectroscopy analysis of lipid droplets content, distribution and saturation level in Non-Alcoholic Fatty Liver Disease in mice. Journal of Biophotonics 8:7, pages 597-609.
Crossref
Crossref
Dao-Yu Tan, Hai-Yan Shi, Chang-Ping Li, Xiao-Ling Zhong & Ming Kang. (2015) Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease. World Journal of Gastroenterology 21:19, pages 5877-5883.
Crossref
Crossref
Satinath Mukhopadhyay, Samim A. Mondal, Manoj Kumar & Deep Dutta. (2014) Proinflammatory and Antiinflammatory Attributes of Fetu Iν-A: A Novel Hepatokine Modulating Cardiovascular and Glycemic Outcomes in Metabolic Syndrome. Endocrine Practice 20:12, pages 1345-1351.
Crossref
Crossref
Noa Mashav & Oren Shibolet. 2014. Liver Metabolism and Fatty Liver Disease. Liver Metabolism and Fatty Liver Disease
3
24
.
Tae-Gue Ahn, Joo-Young Lee, Se-Yun Cheon, Hyo-Jin An & Yoon-Bum Kook. (2013) Protective effect of Sam-Hwang-Sa-Sim-Tang against hepatic steatosis in mice fed a high-cholesterol diet. BMC Complementary and Alternative Medicine 13:1.
Crossref
Crossref
Roya Kelishadi, Sanam Farajian & Maryam Mirlohi. (2013) Probiotics as a Novel Treatment for Non-Alcoholic Fatty Liver Disease; A Systematic Review on the Current Evidences. Hepatitis Monthly 13:4.
Crossref
Crossref
Jr-Ting Lee, Li-Heng Pao, Meei-Shyuan Lee, Jiunn-Wang Liao, Chi-Min Shih, Cheng-Huei Hsiong, Fon-Yi Yin, Tung-Yuan Shih & Oliver Yoa-Pu Hu. (2013) A new approach to facilitate diagnosis of nonalcoholic fatty liver disease through a galactose single point method in rats with fatty liver. Digestive and Liver Disease 45:2, pages 134-141.
Crossref
Crossref
John Willy Haukeland, Tuva B Dahl, Arne Yndestad, Ivar P Gladhaug, Else Marit Løberg, Terese Haaland, Zbigniew Konopski, Cecilie Wium, Erlend T Aasheim, Odd Erik Johansen, Pål Aukrust, Bente Halvorsen & Kåre I Birkeland. (2012) Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies. European Journal of Endocrinology 166:3, pages 503-510.
Crossref
Crossref
Christopher Masterjohn & Richard S Bruno. (2012) Therapeutic potential of green tea in nonalcoholic fatty liver disease. Nutrition Reviews 70:1, pages 41-56.
Crossref
Crossref
Jian Lin, Fake Lu, Wei Zheng, Shuoyu Xu, Dean Tai, Hanry Yu & Zhiwei Huang. (2011) Assessment of liver steatosis and fibrosis in rats using integrated coherent anti-Stokes Raman scattering and multiphoton imaging technique. Journal of Biomedical Optics 16:11, pages 116024.
Crossref
Crossref
Arne Yndestad, John Willy Haukeland, Tuva B. Dahl, Bente Halvorsen & Pål Aukrust. 2011. Activins and Inhibins. Activins and Inhibins
323
342
.
Tuva B. Dahl, John Willy Haukeland, Arne Yndestad, Trine Ranheim, Ivar P. Gladhaug, Jan K. Damås, Terese Haaland, Else Marit Løberg, Borghild Arntsen, Kåre Birkeland, Kristian Bjøro, Stine M. Ulven, Zbigniew Konopski, Hilde I. Nebb, Pål Aukrust & Bente Halvorsen. (2010) Intracellular Nicotinamide Phosphoribosyltransferase Protects against Hepatocyte Apoptosis and Is Down-Regulated in Nonalcoholic Fatty Liver Disease. The Journal of Clinical Endocrinology & Metabolism 95:6, pages 3039-3047.
Crossref
Crossref
Arne Yndestad, John Willy Haukeland, Tuva Børresdatter Dahl, Kristian Bjøro, Ivar Prydz Gladhaug, Christ Berge, Jan Kristian Damås, Terese Haaland, Else Marit Løberg, Paul Linnestad, Kåre Birkeland, Zbigniew Konopski, Bente Halvorsen, Rolf Kristian Berge & Pål Aukrust. (2009) A Complex Role of Activin A in Non-Alcoholic Fatty Liver Disease. The American Journal of Gastroenterology 104:9, pages 2196-2205.
Crossref
Crossref
Michael Nathan VanSaun, In Kyu Lee, Mary Kay Washington, Lynn Matrisian & David Lee Gorden. (2009) High Fat Diet Induced Hepatic Steatosis Establishes a Permissive Microenvironment for Colorectal Metastases and Promotes Primary Dysplasia in a Murine Model. The American Journal of Pathology 175:1, pages 355-364.
Crossref
Crossref
Herbert Tilg & Alexander R. Moschen. (2008) Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends in Endocrinology & Metabolism 19:10, pages 371-379.
Crossref
Crossref
Francesco Fallo, Anna Dalla Pozza, Nicoletta Sonino, Giovanni Federspil, Mario Ermani, Sara Baroselli, Cristiana Catena, Giorgio Soardo, Renzo Carretta, Dario Belgrado, Bruno Fabris & Leonardo A Sechi. (2008) Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients. Journal of Hypertension 26:11, pages 2191-2197.
Crossref
Crossref
Marta Cobo Martín, Pedro Fernández Gil & Javier Crespo. (2008) Tratamiento de la enfermedad hepática por depósito de grasa. Gastroenterología y Hepatología 31:4, pages 229-238.
Crossref
Crossref